- eFFECTOR Therapeutics press release (NASDAQ:EFTR): Q4 GAAP EPS of -$3.42.
- Revenue of $0M.
eFFECTOR Therapeutics GAAP EPS of -$3.42, revenue of $0M
Recommended For You
More Trending News
About EFTR Stock
Related Stocks
| Symbol | Last Price | % Chg |
|---|---|---|
| EFTR | - | - |
| eFFECTOR Therapeutics, Inc. | ||